Isn’t one of the strengths of the Gnbt vaccine that it targets the viral body rather than the spike protein? The spike proteins are the location of greatest mutation. Hence the likelihood that the Gnbt vaccine will be effective with a variety of spike protein mutations. Or am I off base on this?
Generex Biotechnology Corp. (GNBT) Stock Research Links